Radar Therapeutics
PrivateLast Round
Seed
May 23, 2024
Total Funding Raised
$13.4M
Company Overview
Radar Therapeutics is a biotechnology company developing programmable precision mRNA-based therapeutics that use RNA sensors to target pathogenic cells based on their transcriptional signatures.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Radar Therapeutics Comparables
Compare Radar Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Strand Therapeutics | 82% | |
| Therna Biosciences | 75% | |
| Senti Biosciences | 73% |
Radar Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 23, 2024 |
Key People
Founding team and executive leadership
Radar Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BEVC | Seed |
| NFX | Seed |
| Pear VC | Seed |
| Biovision Ventures | Seed |
| KdT Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 23, 2024
$13.4M round led by NFX
Radar Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access